Nvidia received a new Buy recommendation from analysts who cited the company's expanding role as the "AI Backbone of Healthcare and Drug Discovery," reinforcing the strong market sentiment.
- The bullish outlook was further supported by SK Hynix’s announcement that it would spend $12.9 billion on AI memory, driven by robust Nvidia demand.
- Nvidia clarified that customers require no upfront payments for its high-performance H200 chips, easing procurement and supporting accelerated deployment across key sectors.